Using the rat forced swim test to assess antidepressant-like activity in rodents.

Nature Protocols
David A Slattery, John F Cryan

Abstract

The forced swim test (FST) is one of the most commonly used animal models for assessing antidepressant-like behavior. This protocol details using the FST in rats, which takes place over 48 h and is followed by the video analysis of the behavior. The swim test involves the scoring of active (swimming and climbing) or passive (immobility) behavior when rodents are forced to swim in a cylinder from which there is no escape. There are two versions that are used, namely the traditional and modified FSTs, which differ in their experimental setup. For both versions, a pretest of 15 min (although a number of laboratories have used a 10-min pretest with success) is included, as this accentuates the different behaviors in the 5-min swim test following drug treatment. Reduction in passive behavior is interpreted as an antidepressant-like effect of the manipulation, provided it does not increase general locomotor activity, which could provide a false positive result in the FST.

References

Feb 15, 1978·European Journal of Pharmacology·R D PorsoltM Jalfre
Oct 1, 1978·European Journal of Pharmacology·R D PorsoltM Jalfre
Jul 22, 1999·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·D H OverstreetA Parsian
Jan 29, 2000·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·C López-Rubalcava, I Lucki
May 15, 2002·Trends in Pharmacological Sciences·John F CryanIrwin Lucki
Aug 9, 2002·Journal of Affective Disorders·Arun V RavindranHymie Anisman
Jun 19, 2003·JAMA : the Journal of the American Medical Association·Ronald C KesslerUNKNOWN National Comorbidity Survey Replication
Jul 5, 2003·Biological Psychiatry·John F CryanAthina Markou
Sep 23, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Matthew N HillBoris B Gorzalka
Aug 31, 2004·The Journal of Pharmacology and Experimental Therapeutics·David A SlatteryJohn F Cryan
Dec 21, 2004·Psychopharmacology·Benoit Petit-DemouliereMichel Bourin
Feb 3, 2005·Nature Reviews. Drug Discovery·Julio Licinio, Ma-Li Wong
Jun 1, 2005·Behavioural Brain Research·Rafal RygulaUrsula Havemann-Reinecke
Jun 1, 2005·Neuroscience and Biobehavioral Reviews·Keith MatthewsEleanor Sorrell
Sep 3, 2005·Nature Reviews. Drug Discovery·John F Cryan, Andrew Holmes
Dec 27, 2005·Behavioural Pharmacology·Rafal RygulaUrsula Havemann-Reinecke
Jan 13, 2006·Biological Psychiatry·Gregor HaslerHusseini K Manji
Mar 2, 2006·Genes, Brain, and Behavior·T D Gould, I I Gottesman
Dec 5, 2006·Current Opinion in Psychiatry·John F Cryan, David A Slattery
Jun 10, 2010·Journal of Psychopharmacology·David A SlatteryJohn F Cryan

❮ Previous
Next ❯

Citations

Aug 15, 2013·Cell and Tissue Research·Vincenzo MicaleAlexandra Sulcova
Nov 10, 2013·European Journal of Pharmacology·Aashish S MoraniBronwyn M Kivell
Nov 16, 2013·The Journal of Clinical Investigation·Sarah Ann R AndersonYasmin L Hurd
Oct 22, 2013·BMC Complementary and Alternative Medicine·Gwladys Temkou NgoupayeWillie Mark Uren Daniels
Nov 10, 2013·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Ramy E AbdelhamidAlice A Larson
Jan 28, 2014·Journal of Neural Transmission·Ronise M SantiagoMaria A B F Vital
Sep 17, 2014·ILAR Journal·David A Slattery, John F Cryan
Nov 12, 2013·Biological Psychiatry·Chun-Hui Chang, Anthony A Grace
Nov 5, 2014·Neural Regeneration Research·Shruti V Kabadi, Alan I Faden
Jun 14, 2013·Cognitive, Affective & Behavioral Neuroscience·Matthew BoykoAlexander Zlotnik
Jan 3, 2016·Psychoneuroendocrinology·Rozita H AnderbergKarolina P Skibicka
Jun 28, 2015·Neuroscience and Biobehavioral Reviews·Annelies GrimonprezKristl Vonck
Dec 12, 2012·Neuropeptides·Masanobu ItoRemi Quirion
Apr 4, 2015·Neuropharmacology·Nikolaos KokrasChristina Dalla
Apr 2, 2016·Neural Plasticity·E R de Kloet, M L Molendijk
Dec 17, 2015·Molecular Neurobiology·Isabella Caroline da Silva DiasJanaina Menezes Zanoveli
Sep 30, 2015·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·Thaísa M SandiniHelenice de S Spinosa
Jul 23, 2015·Scientific Reports·James O FajemiroyeElson A Costa
Apr 5, 2014·British Journal of Pharmacology·N Kokras, C Dalla
Jan 29, 2014·British Journal of Pharmacology·Claire A HalesEmma S J Robinson
Mar 25, 2016·Canadian Journal of Physiology and Pharmacology·Arya Haj-MirzaianAhmadReza Dehpour
Apr 1, 2016·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Nazanin SoneiMir-Jamal Hosseini

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.